|
Seattle Genetics Inc
Executive Salaries, Bonuses, Stock Options, and Other Compensation
|
| Company Name | Seattle Genetics Inc |
| Stock Symbol | SGEN |
| Business Address | 21823 30TH DRIVE SE
SUITE
BOTHELL, WA 98021 |
| Industry | Biological Products, (No Disgnostic Substances) |
| Fiscal Year-End | 12/31 |
| State of Incorporation | DE |
| Telephone Number | 425-527-4000 |
|
|
Proxy Statement Filing Years -
2008
2007
2006
2005
2004
|
Seattle Genetics Inc filed the compensation data below on 4/16/2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Name and Principal Position
(a) |
|
Year
(b) |
|
Salary ($)
(c) |
|
|
Bonus ($)
(d) |
|
|
Option
Awards
($) (12)
(f) |
|
Non-Equity
Incentive Plan
Compensation
($) (13)
(g) |
|
All Other
Compensation
($) (14)
(i) |
|
|
Total
($) (j) |
| Clay B. Siegall, Ph.D. President and CEO |
|
2007
2006 |
|
486,025
435,400 |
|
|
— — |
|
|
656,919
352,347 |
|
264,870
206,388 |
|
5,365
5,365 |
|
|
1,413,179
999,500 |
|
|
|
|
|
|
|
|
| Todd E. Simpson Chief Financial Officer |
|
2007
2006 |
|
289,243
263,135 |
|
|
2,000 25,000 |
(1) (2) |
|
417,798
431,766 |
|
101,473
84,953 |
|
4,200
3,768 |
|
|
814,714
808,622 |
|
|
|
|
|
|
|
|
| Eric L. Dobmeier Chief Business Officer |
|
2007
2006 |
|
325,446
275,473 |
|
|
5,500 — |
(3) |
|
449,066
298,124 |
|
124,418
103,086 |
|
4,200
4,200 |
|
|
908,630
680,883 |
|
|
|
|
|
|
|
|
| Thomas C. Reynolds, MD., Ph.D. Chief Medical Officer |
|
2007
2006 |
|
256,250 — |
(4) |
|
25,000 — |
(5) |
|
807,872
— |
|
92,318
— |
|
4,200
— |
|
|
1,185,640
— |
|
|
|
|
|
|
|
|
| Morris Z. Rosenberg, D.Sc. SVP, Development |
|
2007
2006 |
|
283,525
258,059 |
|
|
— 500 |
(6) |
|
276,868
247,199 |
|
99,440
83,556 |
|
4,048
4,200 |
|
|
663,881
593,514 |
|
|
|
|
|
|
|
|
| Pamela A. Trail, Ph.D. (7) |
|
2007 |
|
119,346 |
|
|
— |
|
|
695,748 |
|
— |
|
356,466 |
(8) |
|
1,171,560 |
| Former Chief Scientific Officer |
|
2006 |
|
176,077 |
(9) |
|
55,000 |
(10) |
|
290,288 |
|
53,813 |
|
66,108 |
(11) |
|
641,286 |
*The above executive compensation data is an excerpt from the proxy statement filed for
Seattle Genetics Inc on 4/16/2008
|
|
|